Effectiveness Evaluation of a Self-management Program for Prostate Cancer Survivors

NCT05335967 | Completed

• 1 other identifier: 201902235B0C601
• Study Type: interventional
• Target: 85
• Locations: 1 country
• Sites: 2

Brief Summary

Objectives: This project aims to develop a self-management program for survivors with prostate cancer experiencing urinary incontinence following radical prostatectomy and determine its effectiveness. Methods: The investigators will develop a self-management program and conduct a study on survivors with prostate cancer experiencing urinary incontinence following radical prostatectomy. And the investigators will test the effectiveness of the self-management program. After completing a pretest, participants will be randomly assigned to the experimental or control group. The self-management group will receive the self-management program for 12 weeks, whereas the information group will receive an information package on a healthy diet. Posttests will be administered 12 and 16 weeks after the pretest. The study variables will include physical symptoms and bothers, cancer-related self-efficacy, social participation, demoralization, and resilience.

Conditions

Prostatic Neoplasms; Self-Management

Keywords

Prostate cancer; Self-Management; Social participation; Resilience; Rear of cancer recurrence; Self-efficacy; Demoralization

Outcome Measures

Primary Outcomes (3)

• Cancer related self-efficacy

  The Mandarin version of the Cancer Survivors' Self-Efficacy Scale (CSSES) will be used to evaluate the cancer-specific self-efficacy of participants.The total score ranges from 11 to 110; the lower the score, the worse the self-efficacy.

  Pre-test

• Cancer related self-efficacy

  The Mandarin version of the Cancer Survivors' Self-Efficacy Scale (CSSES) will be used to evaluate the cancer-specific self-efficacy of participants.The total score ranges from 11 to 110; the lower the score, the worse the self-efficacy.

  12 weeks after the pretest

• Cancer related self-efficacy

  The Mandarin version of the Cancer Survivors' Self-Efficacy Scale (CSSES) will be used to evaluate the cancer-specific self-efficacy of participants.The total score ranges from 11 to 110; the lower the score, the worse the self-efficacy.

  16 weeks after the pretest

Secondary Outcomes (12)

• Urinary symptoms and bothers

  Pre-test

• Urinary symptoms and bothers

  12 weeks after the pretest

• Urinary symptoms and bothers

  16 weeks after the pretest

• Social participation

  Pre-test

• Social participation

  12 weeks after the pretest

Other Outcomes (13)

• Demographic characteristic and disease information list 1

  Pre-test

• Demographic characteristic and disease information list 2

  Pre-test

• Demographic characteristic and disease information list 3

  Pre-test

Study Arms (2)

Self-management group

EXPERIMENTAL

The experimental group will receive the self-management program for 12 weeks.

Behavioral: Self-management program

Information group

OTHER

The control group will receive an information package on a healthy diet.

Other: Information package

Interventions

Self-management program BEHAVIORAL

The self-management group will receive the self-management program for 12 weeks, including a self-management application, a self-management manual, and Professional support.

Self-management group

Information package OTHER

The patients in this group will receive an information package on a healthy diet.

Information group

Eligibility Criteria

• Age: 20 Years - 80 Years
• Sex: male
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Prostate cancer survivors will include if they fit the following:
• Received radical prostatectomy and suffering from urinary incontinence for at least one week
• Eastern Cooperative Oncology Group 0-1 point, able to walk entirely independently
• Have a smartphone or a tablet with a wireless network
• Their intimate partner or one of the family members willing to learn together
• Agreed to participate in the study and completed the informed consent form

You may not qualify if:

• Prostate cancer survivors will be excluded if they had one or more of the following:
• A request, with the consideration of family members, that the medical team not tell the patient about the diagnosis or condition of the disease
• A history of psychiatric illness, such as dementia, depression; schizophrenia, or bipolar disorder
• Suffer from other types of cancer and actively undergoing treatment

Sponsors & Collaborators

• National Taipei University of Nursing and Health Sciences: lead
• Chang Gung Memorial Hospital: collaborator
• National Science and Technology Council: collaborator

Study Sites (2)

Chang Gung Memorial Hospital at Keelung

Keelung, Taiwan

Location

Chang Gung Memorial Hospital at Linkou

Taoyuan District, 33305, Taiwan

Location

Related Publications (26)

• Chien CH, Liu KL, Wu CT, Chuang CK, Yu KJ, Lin PH, Huang XY, Pang ST. Development and assessment of a self-management intervention for urinary incontinence among patients with prostate cancer: protocol for a randomized feasibility study. BMC Urol. 2023 Nov 18;23(1):193. doi: 10.1186/s12894-023-01367-7.

  PMID: 37980490 BACKGROUND

• Agochukwu NQ, Skolarus TA, Wittmann D. Telemedicine and prostate cancer survivorship: a narrative review. Mhealth. 2018 Oct 8;4:45. doi: 10.21037/mhealth.2018.09.08. eCollection 2018.

  PMID: 30505843 BACKGROUND

• An E, Lo C, Hales S, Zimmermann C, Rodin G. Demoralization and death anxiety in advanced cancer. Psychooncology. 2018 Nov;27(11):2566-2572. doi: 10.1002/pon.4843. Epub 2018 Aug 20.

  PMID: 30053317 BACKGROUND

• Baker H, Wellman S, Lavender V. Functional Quality-of-Life Outcomes Reported by Men Treated for Localized Prostate Cancer: A Systematic Literature Review. Oncol Nurs Forum. 2016 Mar;43(2):199-218. doi: 10.1188/16.ONF.199-218.

  PMID: 26906131 BACKGROUND

• Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977 Mar;84(2):191-215. doi: 10.1037//0033-295x.84.2.191. No abstract available.

  PMID: 847061 BACKGROUND

• Campbell-Sills L, Stein MB. Psychometric analysis and refinement of the Connor-davidson Resilience Scale (CD-RISC): Validation of a 10-item measure of resilience. J Trauma Stress. 2007 Dec;20(6):1019-28. doi: 10.1002/jts.20271.

  PMID: 18157881 BACKGROUND

• Chien CH, Chuang CK, Liu KL, Huang XY, Liu HE. Psychosocial adjustments in patients with prostate cancer from pre-diagnosis to 6 months post-treatment. Int J Nurs Pract. 2016 Feb;22(1):70-8. doi: 10.1111/ijn.12360. Epub 2014 Oct 13.

  PMID: 25307968 BACKGROUND

• Chien CH, Chung HJ, Liu KL, Pang ST, Wu CT, Chang YH, Huang XY, Chang YH, Lin TP, Lin WY, Chuang CK. Effectiveness of a couple-based psychosocial intervention on patients with prostate cancer and their partners: A quasi-experimental study. J Adv Nurs. 2020 Oct;76(10):2572-2585. doi: 10.1111/jan.14471. Epub 2020 Aug 3.

  PMID: 32744426 BACKGROUND

• Chou MC, Chien CH, Chung HJ, Chuang CK, Wu CT, Pang ST, Liu KL, Chang YH. The Psychometric Properties of Taiwanese Version of the Memorial Anxiety Scale for Prostate Cancer. J Pain Symptom Manage. 2021 Apr;61(4):824-830. doi: 10.1016/j.jpainsymman.2020.10.013. Epub 2020 Oct 24.

  PMID: 33198956 BACKGROUND

• Cockle-Hearne J, Faithfull S. Self-management for men surviving prostate cancer: a review of behavioural and psychosocial interventions to understand what strategies can work, for whom and in what circumstances. Psychooncology. 2010 Sep;19(9):909-22. doi: 10.1002/pon.1657.

  PMID: 20119934 BACKGROUND

• Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76-82. doi: 10.1002/da.10113.

  PMID: 12964174 BACKGROUND

• Crafoord MT, Fjell M, Sundberg K, Nilsson M, Langius-Eklof A. Engagement in an Interactive App for Symptom Self-Management during Treatment in Patients With Breast or Prostate Cancer: Mixed Methods Study. J Med Internet Res. 2020 Aug 10;22(8):e17058. doi: 10.2196/17058.

  PMID: 32663140 BACKGROUND

• Faithfull S, Cockle-Hearne J, Khoo V. Self-management after prostate cancer treatment: evaluating the feasibility of providing a cognitive and behavioural programme for lower urinary tract symptoms. BJU Int. 2011 Mar;107(5):783-790. doi: 10.1111/j.1464-410X.2010.09588.x. Epub 2010 Oct 13.

  PMID: 20942826 BACKGROUND

• Foster C, Breckons M, Cotterell P, Barbosa D, Calman L, Corner J, Fenlon D, Foster R, Grimmett C, Richardson A, Smith PW. Cancer survivors' self-efficacy to self-manage in the year following primary treatment. J Cancer Surviv. 2015 Mar;9(1):11-9. doi: 10.1007/s11764-014-0384-0. Epub 2014 Jul 16.

  PMID: 25028218 BACKGROUND

• Foster C, Fenlon D. Recovery and self-management support following primary cancer treatment. Br J Cancer. 2011 Nov 8;105 Suppl 1(Suppl 1):S21-8. doi: 10.1038/bjc.2011.419.

  PMID: 22048029 BACKGROUND

• Frankland J, Brodie H, Cooke D, Foster C, Foster R, Gage H, Jordan J, Mesa-Eguiagaray I, Pickering R, Richardson A. Follow-up care after treatment for prostate cancer: evaluation of a supported self-management and remote surveillance programme. BMC Cancer. 2019 Apr 23;19(1):368. doi: 10.1186/s12885-019-5561-0.

  PMID: 31014282 BACKGROUND

• Jonkman NH, Schuurmans MJ, Groenwold RHH, Hoes AW, Trappenburg JCA. Identifying components of self-management interventions that improve health-related quality of life in chronically ill patients: Systematic review and meta-regression analysis. Patient Educ Couns. 2016 Jul;99(7):1087-1098. doi: 10.1016/j.pec.2016.01.022. Epub 2016 Feb 1.

  PMID: 26856778 BACKGROUND

• Kissane DW, Wein S, Love A, Lee XQ, Kee PL, Clarke DM. The Demoralization Scale: a report of its development and preliminary validation. J Palliat Care. 2004 Winter;20(4):269-76.

  PMID: 15690829 BACKGROUND

• Xu A, Wang Y, Wu X. Effectiveness of e-health based self-management to improve cancer-related fatigue, self-efficacy and quality of life in cancer patients: Systematic review and meta-analysis. J Adv Nurs. 2019 Dec;75(12):3434-3447. doi: 10.1111/jan.14197. Epub 2019 Oct 20.

  PMID: 31566769 BACKGROUND

• Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000 Dec 20;56(6):899-905. doi: 10.1016/s0090-4295(00)00858-x.

  PMID: 11113727 BACKGROUND

• Straczynska A, Weber-Rajek M, Strojek K, Piekorz Z, Styczynska H, Goch A, Radziminska A. The Impact Of Pelvic Floor Muscle Training On Urinary Incontinence In Men After Radical Prostatectomy (RP) - A Systematic Review. Clin Interv Aging. 2019 Nov 12;14:1997-2005. doi: 10.2147/CIA.S228222. eCollection 2019.

  PMID: 31814714 BACKGROUND

• Song L, Guo P, Tan X, Chen RC, Nielsen ME, Birken SA, Koontz BF, Northouse LL, Mayer DK. Enhancing survivorship care planning for patients with localized prostate cancer using a couple-focused web-based, mHealth program: the results of a pilot feasibility study. J Cancer Surviv. 2021 Feb;15(1):99-108. doi: 10.1007/s11764-020-00914-7. Epub 2020 Jul 17.

  PMID: 32681304 BACKGROUND

• Skolarus TA, Metreger T, Wittmann D, Hwang S, Kim HM, Grubb RL 3rd, Gingrich JR, Zhu H, Piette JD, Hawley ST. Self-Management in Long-Term Prostate Cancer Survivors: A Randomized, Controlled Trial. J Clin Oncol. 2019 May 20;37(15):1326-1335. doi: 10.1200/JCO.18.01770. Epub 2019 Mar 29.

  PMID: 30925126 BACKGROUND

• Sharpley CF, Bitsika V, Christie DRH, Bradford R, Steigler A, Denham JW. Psychological resilience aspects that mediate the depressive effects of urinary incontinence in prostate cancer survivors 10 years after treatment with radiation and hormone ablation. J Psychosoc Oncol. 2017 Jul-Aug;35(4):438-450. doi: 10.1080/07347332.2017.1306733. Epub 2017 Mar 20.

  PMID: 28318448 BACKGROUND

• Roth AJ, Rosenfeld B, Kornblith AB, Gibson C, Scher HI, Curley-Smart T, Holland JC, Breitbart W. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Cancer. 2003 Jun 1;97(11):2910-8. doi: 10.1002/cncr.11386.

  PMID: 12767107 BACKGROUND

• Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003 Aug;26(1):1-7. doi: 10.1207/S15324796ABM2601_01.

  PMID: 12867348 BACKGROUND

MeSH Terms

Conditions

Prostatic Neoplasms

Interventions

Self-Management

Condition Hierarchy (Ancestors)

Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Genital Diseases, Male; Genital Diseases; Urogenital Diseases; Prostatic Diseases; Male Urogenital Diseases

Intervention Hierarchy (Ancestors)

Rehabilitation; Health Services; Health Care Facilities Workforce and Services

Study Officials

• Ching-Hui Chien, PhD

  National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: RN, PhD, Professor

Study Record Dates

• First Submitted: April 4, 2022
• First Posted: April 20, 2022
• Study Start: May 20, 2022
• Primary Completion: July 31, 2024
• Study Completion: July 31, 2024
• Last Updated: January 3, 2025

Record last verified: 2023-09

Data Sharing

• IPD Sharing: Will not share

Locations

TW (2)